Talha Badar: Valuating co-mutations patterns of TP53-mutated myeloid neoplasms
Talha Badar, Hematology/Oncology specialist in Mayo Clinic, shared a recent article on X:
“British Journal of Haematology, Wiley Online Library Happy to contribute to this paper by Girish Venkataraman et al evaluating co-mutations patterns, response to treatment and outcome of TP53m myeloid neoplasms.”
Title: Somatic co-alteration signatures are prognostic in high-grade TP53-mutated myeloid neoplasms
Authors: Emily O. Symes, Peng Wang, Payal Sojitra, Madhu P. Menon, Anand A. Patel, Faheema Hasan, Sharmila Ghosh, Gregory W. Roloff, Qianghua Zhou, Anthony Findley, Talha Badar, Jingjing Zhang, Hamza Tariq, Hong Chang, Robert C. Bell, Anamarija M. Perry and Girish Venkataraman.
Dr. Talha Badar, MD, is a specialist in Hematology Oncology based in Mayo Clinic, Jacksonville, Florida. His primary areas of expertise include Leukemia, particularly Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Lymphoblastic Leukemia (ALL), and Bone Marrow Transplantation. Over his career, he has actively contributed to clinical research and clinical trials.
More posts featuring Talha Badar.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023